- Home
- » Tags
- » Mallinckrodt
Top View
- Current Sustaining Member Companies
- Biopharma Boom Fosters Deal Spree
- FORM 10-Q Johnson & Johnson
- Edward Mallinckrodt Jr. Papers (S0452)
- Covidien Aims for Abbvie Mk II with Mallinckrodt Spinout
- Qui Tam Quarterly: Enforcement Trends in False Claims Act Liability for Patient Assistance Programs
- Washington, D.C. Area
- Mallinckrodt Public Limited Company (Name of Registrant As Specified in Its Charter)
- National Prescription ) Case No. 1:17 Md 2804 Op
- Bausch Health 2019 Annual Report
- Declaration of Disclosure Faculty Disclosures
- Mallinckrodt Plc
- IN the UNITED STATES DISTRICT COURT for the DISTRICT of DELAWARE MALLINCKRODT IP, Plaintiff, V. MYLAN LABORATORIES LTD. and AGIL
- January 22, 2018
- 4Q2015 Active Labeler Labeler Company 00002 ELI LILLY and COMPANY 00003 E.R
- Faculty Disclosures
- 20200915 MED-Project Participant List.Xlsx
- United States District Court for the Western District of Kentucky
- 685.1 Cephalon, Inc.; Teva Pharmaceutical Industries Ltd.; Teva Pharmaceuticals USA, Inc.; Endo
- Mallinckrodt Public Limited Company (Exact Name of Registrant As Specified in Its Charter) ______
- Registered Drug Distribution Agents, Manufacturers Wholesalers As of 2/19/21
- ENDO INTERNATIONAL PUBLIC LIMITED COMPANY Directors' Report and Financial Statements for the Year Ended December 31, 2019
- Manufacturer Abbreviations*
- Drug Deilvery & Formulation 2020 Part 2.Indd
- Snippet Roundup: the Good Times Roll for Moderna, but Mallinckrodt and Smith & Nephew Flag
- Global, Diverse, Durable Diverse, Global
- United States District Court for the Middle District of Florida
- AASLD Faculty Disclosures.Xlsx
- Current Sustaining Member Companies
- Paragraph IV Disputes Conference